Evidence map›Paper›PMID 36368139›Full record

ArticleBiomaterials2022

Uncloaking cell-impermeant gold nanorods via tumor microenvironmental cathepsin B facilitates cancer cell penetration and potent radiosensitization.

Subhiksha Raghuram, Yuri Mackeyev, Jessica Symons, Yasmin Zahra, Valeria Gonzalez, Krishnan K Mahadevan, Katherinne I Requejo, Anton Liopo, Paul Derry, Eugene Zubarev and 5 more

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Subhiksha RaghuramDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yuri MackeyevVivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Jessica SymonsDepartment of Integrative Biology and Pharmacology, The University of Texas MD Anderson Cancer Center-UT Health Graduate School of Biomedical Sciences, Houston, TX, USA.
Yasmin ZahraDepartment of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Valeria GonzalezDepartment of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Krishnan K MahadevanDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Katherinne I RequejoDepartment of Chemistry, Rice University, Houston, TX, USA.
Anton LiopoDepartment of Chemistry, Rice University, Houston, TX, USA; Institute of Bioscience and Technology, Texas A&M University, Houston, TX, USA.
Paul DerryDepartment of Chemistry, Rice University, Houston, TX, USA.
Eugene ZubarevDepartment of Chemistry, Rice University, Houston, TX, USA.
Onur SahinDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Materials Science & NanoEngineering, Rice University, Houston, TX, USA.
Joseph Byung-Kyu KimDepartment of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL, USA; Department of Therapeutics and Pharmacology, The University of Texas MD Anderson Cancer Center-UT Health Graduate School of Biomedical Sciences, Houston, TX, USA.
Pankaj K SinghDepartment of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Sang Hyun ChoDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sunil KrishnanVivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX, USA. Electronic address: sunil.krishnan@uth.tmc.edu.
The University of Texas MD Anderson Cancer Center · USRice University · USWinnMed · USThe University of Texas Health Science Center · USThe University of Texas Health Science Center at Houston · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
Rational translation of gold nanoparticle mediated radiosensitization tothe clinicR01CA257241 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Sang Hyun Cho, Sunil Krishnan · 2021 to 2026
$3.1M
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticlesR01DE028105 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KRISHNAN, SUNIL, SKINNER, HEATH DEVIN · 2019 to 2023
$2.4M
Radiation response modulation of tumors using biocongjugated gold nanoparticlesR01CA155446 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHO, SANG HYUN, KRISHNAN, SUNIL · 2011 to 2015
$1.5M
NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA155446NCI NIH HHS R01 CA257241NIDCR NIH HHS R01 DE028105
6 · The paper itself

Abstract

Major impediments to conveyance of intravenously administered drugs to tumors are biofouling, opsonization, and rapid clearance from the circulation by macrophages and reticuloendothelial phagocytes. Cloaking nanoparticles with stealth epilayers partly overcomes these hurdles but it also foils interactions with tumor cells. Here, we describe the synthesis, characterization, and validation of smart gold nanorods (GNRs) that spontaneously transform from inert passengers in the blood stream to active cell-penetrating nanoparticles within tumors to potently sensitize tumors to radiation therapy. Intrinsically cationic and cell-penetrating GNRs were shielded from phagocytosis with a cloaking polyethylene glycol epilayer containing an intervening cleavable peptide. In the absence of an external trigger, this epilayer is clipped off by the tumor microenvironmental protease, cathepsin B, in colorectal cancers to uncloak and expose the free-circulating native unPEGylated GNR that is readily internalized by cancer cells and turn into immovable small clusters of GNRs. Selective uncloaking of GNRs in the tumor reduced off-target toxicity confirmed by hematologic, biochemical, and histopathological analysis of blood, serum, and normal organs, respectively. Subsequent irradiation led to significant tumor growth delay and improved survival of mice. By addressing multiple barriers to efficient transport and cellular internalization of nanoparticles, our results demonstrate that clinically meaningful radiosensitization can be achieved with rationally designed GNRs.

Indexed as

NanotubesNeoplasmsAnimalsCathepsin BGoldMiceTumor MicroenvironmentCathepsin BGoldCathepsin BCleavable peptideColorectal cancerGold nanorodRadiation therapy

Identifiers

PMID36368139
PMCPMC10032210
OpenAlexW4307828418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.